M&A Deal Summary

Hikma Acquires West-Ward Pharmaceutical

On January 1, 1991, Hikma acquired medical products company West-Ward Pharmaceutical

Acquisition Highlights
  • This is Hikma’s 1st transaction in the Medical Products sector.
  • This is Hikma’s 1st transaction in the United States.
  • This is Hikma’s 1st transaction in New Jersey.

M&A Deal Summary
Date 1991-01-01
Target West-Ward Pharmaceutical
Sector Medical Products
Buyer(s) Hikma
Deal Type Add-on Acquisition

Target

West-Ward Pharmaceutical

Eatontown, New Jersey, United States
West-Ward Pharmaceuticals is a generic prescription medication providers in the US offering both oral solid and injectable pharmaceuticals to a growing number of chain stores, wholesalers, distributors, health systems and government agencies.

Search 200,197 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Hikma

London, United Kingdom
Category Company
Founded 1978
Sector Medical Products
Employees9,100
Revenue 2.9B USD (2023)
DESCRIPTION

Hikma develops, manufactures, and markets a broad range of branded and non-branded generic and in-licensed products. Hikma operates through three businesses: “Branded”, “Injectables” and “Generics”, based principally in the Middle East and North Africa ("MENA"), where it is a market leader, the United States and Europe. Hikma was founded in 1978 and is based in London, England.

DEAL STATS #
Overall 1 of 10
Sector (Medical Products) 1 of 5
Type (Add-on Acquisition) 1 of 8
State (New Jersey) 1 of 1
Country (United States) 1 of 4
Year (1991) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-01-01 ribosepharm

Graefelfing, Germany

ribosepharm GmbH markets a portfolio of products for the treatment of various cancer indications, eg. as colorectal tumors and hematologic diseases.

Buy -
Mergr

Product

Company

Legal